Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-10 Purchase |
2025-01-14 4:05 pm |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
210,791 | $0.96403 | $203,209 | 299,286 (Direct) |
View |
| 2023-12-01 Purchase |
2023-12-05 4:30 pm |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
88,495 | $1.41 | $124,778 | 161,332 (Indirect Direct) |
View |
| 2022-03-16 Purchase |
2022-03-18 06:46 am |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
80,079 | $2.344 | $187,705 | 816,835 (Indirect Direct) |
View |
| 2022-03-11 Purchase |
2022-03-15 6:32 pm |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
144,666 | $1.942 | $280,943 | 739,756 (Indirect Direct) |
View |
| 2021-12-09 Purchase |
2021-12-13 8:39 pm |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
53,634 | $3.7098 | $198,972 | 595,090 (Indirect Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 07:30 am |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
165,000 | $4.75 | $783,750 | 538,469 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-06 Option Award |
2024-06-10 4:05 pm |
N/A 2034-06-05 |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:15 pm |
N/A 2033-06-07 |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:05 pm |
N/A 2032-06-08 |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
19,200 | $0 | 19,200 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 4:57 pm |
N/A 2032-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2018-12-28 Ownership |
2022-02-14 5:19 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
266,295 | $0 | 537,640 (Direct) |
View |
| 2021-10-28 Gift |
2021-10-29 4:01 pm |
N/A N/A |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
72,837 | $0 | 72,837 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:22 pm |
2022-06-30 2031-06-29 |
Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:08 pm |
N/A 2031-06-08 |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:08 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO |
330,000 | $0 | 330,000 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 4:16 pm |
2021-06-30 2030-06-30 |
Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-16 Conversion |
2020-06-18 5:31 pm |
N/A N/A |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
84,030 | $0 | 72,837 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 5:23 pm |
N/A 2030-06-10 |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
52,000 | $0 | 52,000 (Direct) |
View |
Ownership |
2020-06-11 8:33 pm |
N/A N/A |
Generation Bio Co. | GBIO | Quinn Anthony G. Director |
0 | $0 | 72,837 (Direct) |
View |